The Race to Real-Time Cell Therapy Manufacturing

Pharmaceutical leaders adopt Real-Time Cell Therapy Manufacturing to improve speed, ensure quality release, and support faster patient access to treatments.

Vector Manufacturing Meets Rising Gene Therapy Demand

Vector manufacturing meets rising gene therapy demand as Biopharma leaders try to optimize viral vector yield, improve suspension culture and scale production.

How CAR-T Manufacturing Is Breaking the 14-Day Barrier

Pharmaceutical leaders adopt CAR-T Manufacturing strategies to reduce vein-to-vein time, accelerate cell expansion, and improve patient access to oncology care.

Why Living Drugs Need a New Generation of Fill-Finish

Living drugs need a new generation of fill-finish as pharmaceutical leaders try to ensure aseptic integrity, small batch precision, and safe cryopreservation.

Why Modular GMP Facilities are Scaling Faster Than Ever

Pharmaceutical leaders adopt Modular GMP Facilities to accelerate speed to market, improve facility flexibility, and scale biomanufacturing production faster.